目的探讨老年急性白血病的个体化治疗方案。
Objective To explore individualized chemotherapy program of elderly acute leukemia.
目的探讨老年急性白血病治疗个体化化疗方案。
Objective To look for individual chemotherapy program of aged acute leukemia patients.
结论MTT药敏试验对于老年急性白血病选择个体化的化疗方案有指导意义。
Conclusion Drug sensitive test of MTT assay has guidance value for individual chemotherapy program of aged acute leukemia.
探讨老年急性髓细胞性白血病的有效治疗方案。
To explore of the efficient treating method for acute myeloid leukemia in the elderly.
目的探讨70岁以上老年急性髓性白血病临床及生物学特征、影响预后的因素及个体化治疗方案。
Objective to explore the clinical and biological features, prognostic factors and individualized treatment regimen of acute myelogenous leukemia patients over 70 years old.
目的为进一步了解老年人急性白血病的分子生物学特征。
Objective To get insight of molecular biological characteristics of acute leukemia in the elderly.
目的检测P170糖蛋白在初治老年急性髓系白血病（AML）的表达，并探讨其与预后的关系。
Objective To explore the expression of P170 protein in untreated elder AML and its correlation with prognosis.
目的研究老年初治急性髓细胞白血病（AML）的治疗。
Objective To study the therapy of previously untreated elderly patients with acute myeloid leukemia(AML. )
摘要：老年急性髓系白血病(aml)患者治疗耐受性差，预后不佳。
ABSTRACT: Elderly patients with acute myeloid leukemia (AML) tolerate intensive chemotherapy poorly and usually have poor prognosis.
背景和目的：难治性急性髓系白血病(aml)包括复发性aml、原发耐药aml、老年aml及继发aml，是目前白血病治疗困难的类型。
Background and objective: Relapse AML, refractory AML, AML in the old and secondary AML are all AML subtypes hard to cure.
目的探讨老年人急性白血病的免疫表型特点。
Objective To study the immunophenotypic heterogeneity of acute leukemia in elderly.
结果急性白血病诱导化疗期间真菌感染发生率为13.8%。发生真菌感染的危险因素有老年、高白细胞以及使用广谱抗生素时间较长。
Results the incidence of invasive fungal infection is 13.8%, elderly patients, higer WBC counts and longer antibiotics treatment are the risk factor for the fungal infection.
结果急性白血病诱导化疗期间真菌感染发生率为13.8%。发生真菌感染的危险因素有老年、高白细胞以及使用广谱抗生素时间较长。
Results the incidence of invasive fungal infection is 13.8%, elderly patients, higer WBC counts and longer antibiotics treatment are the risk factor for the fungal infection.
应用推荐